Status:
UNKNOWN
Non Invasive Ventilation for Acute Exacerbations in Adult CF
Lead Sponsor:
Manchester Metropolitan University
Collaborating Sponsors:
Manchester University NHS Foundation Trust
Conditions:
Cystic Fibrosis
Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cystic Fibrosis (CF) is a life limiting illness. Median predicted UK survival is 41.4 years (UK CF Registry 2011). The commonest cause of death is respiratory failure. Non invasive ventilation (NIV) ...
Detailed Description
Design: The study will use a mixed methodology and it will be in 2 phases. Phase I A group randomised controlled trial The following measurements will be performed on days 1, 3, 7, 10, 14 and twice w...
Eligibility Criteria
Inclusion
- Adult Cystic Fibrosis
- Hospital admission to Pearce Ward Manchester Adult Cystic Fibrosis Centre
- Acute respiratory exacerbation conforming with a standard definition of pulmonary exacerbation (Fuchs et al 1994).
- An admission day time CO2 \> 6 kilopascal (kPa) on standard therapy
- Freely given informed consent.-
- 3.15 substantial amendment approval for an admission early morning CO2 \> 6 kPa
Exclusion
- A day time CO2 \>8.0 kPa
- respiratory acidosis
- clinical exclusion by CF consultant physician or clinical psychologist
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2017
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02234401
Start Date
August 1 2014
End Date
September 1 2017
Last Update
March 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester Adult Cystic Fibrosis Centre, University Hospitals South Manchester
Wythenshawe, Manchester, United Kingdom, M23 9LT